S. Trent

发表

Reﬂections on EchoCRT: sound guidance on QRS duration and morphology for CRT?

M. Petrou, S. Myerson, Anne E Davis, 2015 .

Retrospective audit of 957 consecutive 18F-FDG PET–CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma

K. Bradley, A. Hassan, N. Athanasou, 2018, Clinical Sarcoma Research.

Innominate artery pleomorphic sarcoma imaged with cardiovascular magnetic resonance and Positron Emission Tomography-Computed Tomography.

M. Petrou, S. Myerson, Anne E Davis, 2015, European heart journal.

Nomogram Predicting the Risk of Postoperative Major Wound Complication in Soft Tissue Sarcoma of the Trunk and Extremities after Preoperative Radiotherapy

Z. Ouyang, D. Whitwell, T. Cosker, 2022, Cancers.

Epidermal Growth Factor Receptor Expression Is a Candidate Target of the Synergistic Combination of Trastuzumab and Flavopiridol in Breast Cancer 1

E. Schmidt, R. Nahta, Chuanwei Yang, 2003 .

Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.

T. Shioda, D. Sgroi, E. Schmidt, 2006, Cancer research.

Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity.

E. Schmidt, Chuanwei Yang, M. Lynch, 2007, Cancer research.

Cervical cancer during the covid pandemic: Are patients presenting with more advanced or larger tumours?

S. Kehoe, S. El-Tawab, S. Trent, 2023, European journal of obstetrics, gynecology, and reproductive biology.

Surgical outcome of malignant primary bone tumours in elderly and very elderly patients

P. Lechler, N. Athanasou, D. Whitwell, 2014, International Orthopaedics.

Epidermal growth factor receptor expression is a candidate target of the synergistic combination of trastuzumab and flavopiridol in breast cancer.

E. Schmidt, R. Nahta, Chuanwei Yang, 2003, Cancer research.